(Q57381955)

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Colloidal carriers for ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

The potential of chitosan in ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Cationic vectors in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Stability and ocular tolerance of cyclophosphamide-loaded nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Cyclosporine A delivery to the eye: A pharmaceutical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Applications of microemulsion based drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

In situ-forming hydrogels for sustained ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Applications of liposomes in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325

Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17469899.3.3.325